NAS:KROS (USA)

Keros Therapeutics Inc $ 56.67 -6.79 (-10.7%)

Volume:
90,674
Avg Vol (1m):
130,465
Market Cap $:
1.32 Bil
Enterprise Value $:
1.05 Bil
PE Ratio:
0.00
PB Ratio:
5.02
Warning! GuruFocus has detected 1 Severe warning sign with KROS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Financial Strength

4/10
Current Vs Industry Vs History
Cash-To-Debt 295.75
Debt-to-EBITDA -0.02
N/A
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
DISTRESS
GREY
SAFE
Beneish M-Score 0
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -1302.54 %
WACC 7.55 %

Profitability Rank

1/10
Current Vs Industry Vs History
Operating Margin % -1866.28
Net Margin % -1814.44
ROE % -38.76
ROA % -36.02
ROC (Joel Greenblatt) % -2458.6

Valuation Rank

Current Vs Industry Vs History
PB Ratio 5.02
EV-to-EBIT -23.89
N/A
EV-to-EBITDA -24.02
N/A
Current Ratio 37.27
Quick Ratio 37.27

Dividend & Buy Back

Current Vs Industry Vs History

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 5.02
Earnings Yield (Greenblatt) % -4.18